In AD, NF-κB is activated by pro-inflammatory cytokines, thus leading to the up-regulation of immune response-related genes and the inflammatory cascade and resulting in the production of additional pro-inflammatory cytokines and the recruitment of additional immune cells to the site of inflammation. Here, NFKB1 is linked to Alzheimer disease.